Where do Stoke Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Stoke Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	-577.5%-597pp	-11.2%+266pp	13.2%+714pp	20.2%+776pp	20%+1,530pp
Net margin	-529.2%-556pp	-3.7%+240pp	19.7%+650pp	26.3%+710pp	26.3%+1,410pp
EBITDA margin	-572.1%-593pp	-10.2%+261pp	14.1%+701pp	21.1%+761pp	21.1%+1,500pp
Returns
Return on equity	-45.6%-66.1pp	-2.4%+43.4pp	15%+67.1pp	18.2%+66.0pp	20.5%+81.8pp
Return on assets	-39.9%-56.4pp	-2%+33.6pp	12.4%+52.0pp	15.2%+51.8pp	16.4%+61.0pp
Return on invested capital	-114.4%—	——	——	——	——
Efficiency
Asset turnover	0.1×-0.5×	0.5×+0.4×	0.6×+0.6×	0.6×+0.5×	0.6×+0.6×
Liquidity
Current ratio	9×+0.6×	5.3×-0.5×	6.5×+1.4×	7×+0.3×	8.4×+3.0×
Quick ratio	9×+0.6×	5.3×-0.5×	6.5×+1.4×	7×+0.3×	8.4×+3.0×
Cash ratio	3.8×-2.3×	1.5×-1.7×	2×-1.0×	2.6×-1.7×	6.2×+1.1×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Interest coverage	-13×-15.9×	-1.5×+6.5×	2.1×+11.6×	3.1×+13.1×	2.9×+14.5×
Per Share
Book value per share	$6.26+6.2%	$5.95+40.4%	$5.26+27.6%	$5.74+31.9%	$5.89+94.2%
Valuation
Market capitalization	$1.93B+436%	$1.81B+210%	$1.29B+87.9%	$628.41M+0.6%	$359.62M-42.4%
Enterprise value	$1.77B+1,855%	$1.73B+276%	$1.21B+123%	$532.22M+21.7%	$90.75M-79.9%
Price / sales	60×+58.2×	9.8×-6.2×	6.3×-34.7×	3.1×-38.1×	1.9×-77.7×
Price / book	4.9×+3.8×	5.1×+2.6×	4.2×+1.2×	1.9×-0.7×	1×-3.4×
EV / sales	55.3×+54.8×	9.4×-3.2×	5.9×-26.4×	2.7×-26.2×	0.5×-57.2×
Earnings yield	-8.8%-22.8pp	-0.4%+14.9pp	3.2%+18.5pp	8.4%+24.9pp	14%+31.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Stoke Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Stoke Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.